Madrigal Pharmaceuticals
MDGL on XNAS, Madrigal Pharmaceuticals, Inc.
Measures activity, not value. Not investment advice.
Shares sold short (30 Oct 2026)
2.1M
-2.6% vs the report before
Short interest, % of shares outstanding
9.2%
23.2M shares outstanding (29 Oct 2026)
Days to cover
7.6
short interest / daily volume
Short sale volume share (20 Nov 2026)
39%
1-year median 58%
Sharp changes
3
short interest spike
FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.
See the numbers
| 30 Oct 2026: 2.1M shares sold short, 7.6 days to cover |
| 15 Oct 2026: 2.2M shares sold short, 7.2 days to cover |
| 30 Sep 2026: 2.4M shares sold short, 9.8 days to cover |
| 15 Sep 2026: 2.3M shares sold short, 11.4 days to cover |
| 31 Aug 2026: 2.2M shares sold short, 9.5 days to cover |
| 14 Aug 2026: 2.0M shares sold short, 6.0 days to cover |
| 31 Jul 2026: 2.0M shares sold short, 4.8 days to cover |
| 15 Jul 2026: 2.1M shares sold short, 6.9 days to cover |
| 30 Jun 2026: 3.5M shares sold short, 6.2 days to cover |
| 15 Jun 2026: 3.8M shares sold short, 14.3 days to cover |
| 29 May 2026: 3.8M shares sold short, 14.1 days to cover |
| 15 May 2026: 3.9M shares sold short, 12.3 days to cover |
| 30 Apr 2026: 3.9M shares sold short, 16.5 days to cover |
| 15 Apr 2026: 4.0M shares sold short, 12.7 days to cover |
| 31 Mar 2026: 3.9M shares sold short, 9.1 days to cover |
| 13 Mar 2026: 3.9M shares sold short, 13.9 days to cover |
| 27 Feb 2026: 3.7M shares sold short, 8.2 days to cover |
| 13 Feb 2026: 3.6M shares sold short, 11.1 days to cover |
| 30 Jan 2026: 4.0M shares sold short, 12.7 days to cover |
| 15 Jan 2026: 3.9M shares sold short, 9.8 days to cover |
| 31 Dec 2025: 3.7M shares sold short, 13.1 days to cover |
| 15 Dec 2025: 3.7M shares sold short, 14.0 days to cover |
| 28 Nov 2025: 3.7M shares sold short, 10.0 days to cover |
| 14 Nov 2025: 3.8M shares sold short, 7.4 days to cover |
| 31 Oct 2025: 3.7M shares sold short, 12.7 days to cover |
| 15 Oct 2025: 3.7M shares sold short, 13.9 days to cover |
| 30 Sep 2025: 3.7M shares sold short, 10.9 days to cover |
| 15 Sep 2025: 4.1M shares sold short, 12.8 days to cover |
| 29 Aug 2025: 4.0M shares sold short, 9.3 days to cover |
| 15 Aug 2025: 3.8M shares sold short, 8.4 days to cover |
| 31 Jul 2025: 4.0M shares sold short, 8.8 days to cover |
| 15 Jul 2025: 3.8M shares sold short, 16.0 days to cover |
| 30 Jun 2025: 4.0M shares sold short, 12.2 days to cover |
| 13 Jun 2025: 4.2M shares sold short, 13.9 days to cover |
| 30 May 2025: 3.9M shares sold short, 12.1 days to cover |
| 15 May 2025: 4.0M shares sold short, 10.3 days to cover |
| 30 Apr 2025: 4.1M shares sold short, 11.4 days to cover |
| 15 Apr 2025: 4.0M shares sold short, 11.5 days to cover |
| 31 Mar 2025: 4.0M shares sold short, 17.0 days to cover |
| 14 Mar 2025: 4.1M shares sold short, 8.5 days to cover |
| 28 Feb 2025: 3.8M shares sold short, 8.7 days to cover |
| 14 Feb 2025: 3.8M shares sold short, 10.7 days to cover |
| 31 Jan 2025: 4.0M shares sold short, 8.6 days to cover |
| 15 Jan 2025: 4.1M shares sold short, 9.0 days to cover |
| 31 Dec 2024: 4.1M shares sold short, 12.6 days to cover |
| 13 Dec 2024: 4.7M shares sold short, 16.0 days to cover |
| 29 Nov 2024: 4.3M shares sold short, 11.3 days to cover |
| 15 Nov 2024: 4.4M shares sold short, 5.4 days to cover |
| 31 Oct 2024: 4.5M shares sold short, 12.5 days to cover |
| 15 Oct 2024: 4.1M shares sold short, 14.4 days to cover |
| 30 Sep 2024: 3.9M shares sold short, 13.8 days to cover |
| 13 Sep 2024: 3.7M shares sold short, 17.9 days to cover |
| 30 Aug 2024: 3.8M shares sold short, 20.0 days to cover |
| 15 Aug 2024: 3.8M shares sold short, 9.8 days to cover |
| 31 Jul 2024: 3.7M shares sold short, 14.1 days to cover |
| 15 Jul 2024: 4.1M shares sold short, 16.3 days to cover |
| 28 Jun 2024: 4.1M shares sold short, 10.1 days to cover |
| 14 Jun 2024: 4.4M shares sold short, 5.6 days to cover |
| 31 May 2024: 5.2M shares sold short, 13.2 days to cover |
| 15 May 2024: 4.2M shares sold short, 9.9 days to cover |
What the numbers say
- 2.1M shares sold short on 30 Oct 2026, 9.2% of shares outstanding, 7.6 days to cover; -2.6% on the report before (published by FINRA on 10 Nov 2026).
Every measure from this source
Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.
Sharp changes
3 in all loaded history, strongest first
Madrigal Pharmaceuticals had 5.2M shares sold short in the 31 May 2024 report, 3.6× the same report last year.
Same report last year: 1.5M; its normal report is 3.2M.
See the evidence
- This period
- 5.2M (the 31 May 2024 report)
- Normal report (median of 24 earlier)
- 3.2M
- Typical spread (median absolute deviation)
- 272K
- How far from its usual level
- +5.0
- Same report last year
- 1.5M
- History used
- 2,345 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Madrigal Pharmaceuticals had 3.4M shares sold short in the 30 Apr 2020 report, 1.6× the same report last year.
Same report last year: 2.1M; its normal report is 2.5M.
See the evidence
- This period
- 3.4M (the 30 Apr 2020 report)
- Normal report (median of 24 earlier)
- 2.5M
- Typical spread (median absolute deviation)
- 73K
- How far from its usual level
- +3.7
- Same report last year
- 2.1M
- History used
- 853 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Madrigal Pharmaceuticals had 3.4M shares sold short in the 15 Apr 2020 report, 1.7× the same report last year.
Same report last year: 2.0M; its normal report is 2.5M.
See the evidence
- This period
- 3.4M (the 15 Apr 2020 report)
- Normal report (median of 24 earlier)
- 2.5M
- Typical spread (median absolute deviation)
- 74K
- How far from its usual level
- +3.7
- Same report last year
- 2.0M
- History used
- 838 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.